CN209137759U - A kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia - Google Patents
A kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia Download PDFInfo
- Publication number
- CN209137759U CN209137759U CN201820648943.9U CN201820648943U CN209137759U CN 209137759 U CN209137759 U CN 209137759U CN 201820648943 U CN201820648943 U CN 201820648943U CN 209137759 U CN209137759 U CN 209137759U
- Authority
- CN
- China
- Prior art keywords
- trigeminal neuralgia
- semi
- transdermal patch
- oxygen saturation
- blood oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010044652 trigeminal neuralgia Diseases 0.000 title claims abstract description 32
- 238000002513 implantation Methods 0.000 title claims abstract description 19
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 239000008280 blood Substances 0.000 title claims abstract description 15
- 210000004369 blood Anatomy 0.000 title claims abstract description 15
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 15
- 239000001301 oxygen Substances 0.000 title claims abstract description 15
- 238000001467 acupuncture Methods 0.000 claims abstract description 10
- 235000014676 Phragmites communis Nutrition 0.000 claims description 17
- 238000001514 detection method Methods 0.000 claims description 4
- 239000004020 conductor Substances 0.000 claims description 3
- 238000005452 bending Methods 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 230000000202 analgesic effect Effects 0.000 abstract description 6
- 230000001815 facial effect Effects 0.000 abstract description 5
- 238000005424 photoluminescence Methods 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 2
- 238000004088 simulation Methods 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 230000036592 analgesia Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 102400000748 Beta-endorphin Human genes 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 108010065372 Dynorphins Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000003840 Opioid Receptors Human genes 0.000 description 1
- 108090000137 Opioid Receptors Proteins 0.000 description 1
- 244000089486 Phragmites australis subsp australis Species 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 102100024622 Proenkephalin-B Human genes 0.000 description 1
- 206010040026 Sensory disturbance Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007056 liver toxicity Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000002719 stereotactic radiosurgery Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
Landscapes
- Finger-Pressure Massage (AREA)
Abstract
The utility model relates to the field of medical instrument technology, and in particular to a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia.At least one secondary transdermal patch for specifically including impulse generator, being connected by conducting wire with impulse generator, the transdermal patch are equipped at least one jack for being used to be inserted into needle thorn, and needle thorn is inserted in jack, and needle thorn is connect with the conducting wire being located in transdermal patch.The electro photoluminescence of half implantation can be carried out to target acupuncture point, and both electro photoluminescence combination is carried out by the way that simulation trigeminal neuralgia to be attached on skin of face in the transdermal patch that facial distributing position makes, 2/100Hz dilatational wave is issued by electric stimulus generator, generate analgesic effect, the pain status for improving primary trigeminal neuralgia, it is safe with using, it is easy to operate, it is not limited by time, space, patient is easy to receive and adhere to using treatment.
Description
Technical field
The utility model relates to the field of medical instrument technology, and in particular to a kind of semi-implantation type warp for treating trigeminal neuralgia
Skin electric acupoint stimulation instrument.
Background technique
It is at present drug oral and operative treatment for the main treatment method of primary trigeminal neuralgia PTN.Karma west
Flat Carbamazepine, CBZ are the fiest-tire medications for treating trigeminal neuralgia, but exist simultaneously many problems, for example take for a long time
Be also easy to produce it is additive, after drug withdrawal without analgesia aftereffect, there is fash, oligoleukocythemia, there is apparent gastrointestinal reaction and liver
Toxicity has drug resistance, it may appear that the serious adverse reactions such as headache, incoordination.Surgical operation therapy mainly includes pulse radiation frequency
Art, Radio frequency thermoset, gamma knife, glycerol injections block art, Percutaneous microballoon compression for trigeminal art, Stereotactic Radiosurgery
With microvascular decompression etc..Studies have pointed out that surgical operation therapy PTN has certain curative effect, but also has certain limitation, such as
Postoperative easy to recur, curative effect maintains the period short, and postoperative complications are inevitable, and the most common are patient facial region's sensory disturbances, chewing
Inability, face fiber crops, dysacousis etc., in addition to fear of operation etc. on patients ' psychological, so that operative treatment can not also become treatment
The main method of PTN.
Neuralgic precedent is also treated using electric stimulating instrument at present, such as 103949011 A of application publication number CN, application is public
The Chinese utility model patent of cloth day 2014.07.30 discloses a kind of portable mobile wireless transcutaneous electrical stimulation instrument, tool
Body discloses following technical scheme: the transcutaneous electrical stimulation instrument includes: remote controler, host and therapeutic electrode, described distant
Control device is connect with host wireless telecommunications；It there are two the therapeutic electrode includes at least, and is symmetrically affixed on electrode slice, the electrode
Piece is connected by snap-fastener with the host, and human body surface is directly adhered to；The pulse generating circuit contains two output ends,
For generating the bi-directional pulse waveforms of different type, different frequency；The impulse waveform includes three kinds of analgesia waveforms and two kinds of calmness
Waveform, the pulse generating circuit output end are connected with the electrode slice respectively, the impulse wave of some strength and frequency are led to
It crosses electrode and acts on human body formation current loop, regularly stimulation nerve, muscle and cell, exciting human generate analgesia peptides
Substance slows down pain to hinder the conduction of pain signal；Four input terminals of pulse generating circuit are connected respectively to single-chip microcontroller
Mouthful, it is encoded according to the level of output height, the on state for controlling triode exports corresponding continuous impulse waveform.Program master
If for mitigating the pain of puerpera in the progress of labor.
But the pain of puerpera be for the moment, and trigeminal neuralgia can continue more long, difficulty is bigger in treatment, therefore, mesh
Preceding electric stimulating instrument can not be well adapted for the illness of trigeminal neuralgia.
Utility model content
Purpose of the utility model is to solve the above problems, provide a kind of semi-implantation type warp for treating trigeminal neuralgia
Skin electric acupoint stimulation instrument.
In order to reach above-mentioned purpose of utility model, the utility model uses following technical scheme:
A kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia, including impulse generator, pass through conducting wire
The secondary transdermal patch of at least one to be connected with impulse generator, the transdermal patch are equipped at least one and are used to be inserted into inserting for needle thorn
Hole, needle thorn is inserted in jack, and needle thorn is connect with the conducting wire in transdermal patch.
Preferably, it is provided at jack in the transdermal patch for transdermal patch inside conductor and needle to be pierced connection
Contact.
Preferably, the contact includes the main body of annular, and main body is equipped with several by the surrounding spring that the heart extends thereto
Piece, the end of each reed connect or cooperatively form the bearing holes of carrying needle thorn in the center of the main body of annular, and the reed is bullet
Property structure.
Preferably, the end that the reed is located at main center is equipped with anti-overturning of bending downward.
Preferably, the needle thorn body is equipped with anti-down line, and anti-down line and reed cooperate.
Preferably, at least one jack corresponds to Xiaguan point.
Preferably, the needle thorn is 0.18*25mm acupuncture needle.
Preferably, needle thorn surface is equipped with scale.
Preferably, the transdermal patch is three forked, and is matched with the distributed areas of facial trigeminal neuralgia.
Preferably, the impulse generator includes detection device and is automatically turned off device.
Preferably, hollow needle guard is equipped in the jack, needle thorn is inserted into hollow needle guard, the excessively hollow needle guard of needle transfixation with
Conducting wire connection in transdermal patch.
Compared with prior art, beneficial effect is the utility model: the electro photoluminescence of half implantation can be carried out to target acupuncture point,
And electro photoluminescence is carried out by the way that simulation trigeminal neuralgia to be attached on skin of face in the transdermal patch that facial distributing position makes
The two combines, and issues 2/100Hz dilatational wave by electric stimulus generator, i.e. generation analgesic effect, improves primary trigeminal neuralgia
The pain status of pain has using safe, easy to operate, is not limited by time, space, and patient is easy to receive and adhere to using controlling
It treats.
Detailed description of the invention
Fig. 1 is the structural schematic diagram of the utility model；
Fig. 2 is the contact plate structure schematic diagram of the utility model；
Fig. 3 is the fit structure schematic diagram of the needle thorn and contact of the utility model；
Fig. 4 is the needle thorn and another structural schematic diagram of contact cooperation of the utility model；
Fig. 5 is a kind of improvement structural schematic diagram of the needle thorn of the utility model.
In figure: 1 impulse generator, 2 transdermal patch, 3 jacks, 4 needles thorn, 5 contacts, 6 main bodys, 7 reeds, 8 bearing holes, 11
Detection device, 12 are automatically turned off device, 13 hollow needle guards.
Specific embodiment
Explanation is further described to the technical solution of the utility model below by specific embodiment.
If raw material employed in the embodiments of the present invention is raw material commonly used in the art without specified otherwise,
Method employed in embodiment is the conventional method of this field.
Embodiment 1:
A kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia, as shown in Fig. 1-3, including pulse hair
Raw device 1, at least one pair transdermal patch 2 being connected by conducting wire with impulse generator 1 are covered with electrode 14 in transdermal patch 2；By
Two sides are up in usual trigeminal neuralgia, therefore two width transdermal patch 2, still, the ordinary circumstance actually used are set here
There was only a pair down；Then it is equipped at least one jack 3 for being used to be inserted into needle thorn 4 on transdermal patch 2, is inserted with needle in jack 3
Thorn 4, needle thorn 4 are connect with the conducting wire being located in transdermal patch 2.4 pairs of trifacial related acupuncture points are pierced by needle to treat, when
So, the corresponding Xiaguan point of at least one jack 3 is needed.Needle thorn 4 setting how much according to the actual situation depending on, in general, by necessary
It is reserved at acupuncture point.Achieve the purpose that treatment by the cooperation of cooperation transdermal patch 2 and needle thorn 4.Needle thorn 4 use as specification for
The acupuncture needle of 0.18*25mm.And the acupuncture needle is into improvement design is crossed, and e.g., pierces 4 surfaces in needle and is equipped with scale etc..
It is provided with specifically, being located at jack 3 in the transdermal patch 2 for 2 inside conductor of transdermal patch and needle to be pierced 4
The contact 5 of connection.Needle thorn is fixed and is electrically connected by contact 5.Specific as follows about the structure of contact 5: contact 5 includes
The main body 6 of annular, main body 6 are equipped with several by the surrounding reed 7 that the heart extends thereto, and the end of each reed 7 is in annular
The center of main body 6, which connects or cooperatively forms, carries the bearing holes 8 that needle pierces 4, and the reed 7 is elastic construction.Reed 7 is in radiation
Shape, central symmetry, outer end are set in main body 6, and inner end is gathered to center, form one for placing the bearing holes 8 of needle thorn.
In addition, transdermal patch 2 is three forked, and matches with face mask, particularly with the distribution of facial trigeminal neuralgia
Region matches；Impulse generator 1 includes detection device 11 and is automatically turned off device 12, reaches two kinds of function using both components
Can, to control therapeutic process.
Over the course for the treatment of, 2/100Hz dilatational wave is issued by impulse generator 1, i.e. generation analgesic effect, improved primary
Property trigeminal neuralgia pain status, have using safe, it is easy to operate, limit by time, space, patient be easy to receive with
Adhere to that, using treatment, patient can just select to control using corresponding transdermal patch according to the sore place of oneself in face's which side
It treats.
In addition, the present embodiment is covered on the acupuncture points on the human body output 2/ of the trigeminal neuralgia distributed areas of face using transdermal patch
100Hz dilatational wave treats primary trigeminal neuralgia, on the one hand because 2/100Hz can excite nerve center while discharge brain coffee
3 kinds of peptide, β endorphin and dynorphin analgesia media, the opioid of release are mutually tied with the opiate receptor of pain sensitized neurons
It closes, reduces the nerve to the sensibility of damage stimulation, to reach analgesic effect；On the other hand, existing research confirmation is held
Continuous to give rat 100Hz acusector up to 10 minutes or more, analgesic effect is decreased obviously, and illustrates that rat generates 100Hz acusector
At this moment tolerance changes acusector frequency and arrives 2Hz, analgesic activity reproduction, and can continue 60 minutes, illustrate that different frequency acusector is not easy
Cross tolerance is generated, so chronic ache is treated using dilatational wave 2/100Hz.
To sum up, this programme is treated using transdermal patch 2 and Acupuncture, can reach good therapeutic effect.
Embodiment 2:
On the basis of embodiment 1, it is further improved, as shown in figure 4, specific as follows:
The end setting that reed 7 is located at 6 center of main body bend downward it is anti-overturn, anti-overturn and can prevent by being arranged
Needle thorn 4 exits, and improves stability, it is also possible to be equipped with anti-down line on the ontology of needle thorn 4, anti-down line and reed 7 cooperate,
Specific is exactly to keep needle thorn 4 steady during the entire course for the treatment of using the cooperation of the two with the anti-cooperation of overturning on reed 7
Surely it is placed on transdermal patch 2.
As shown in figure 5, being equipped with hollow needle guard 13 in the jack 3, needle thorn 4 is inserted into hollow needle guard 14, and needle thorn 4 passes through
Hollow needle guard 13 is connect with the conducting wire in transdermal patch 2.Such setting can improve treatment convenience convenient for the plug of needle thorn 4
Property.
Claims (10)
1. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia, which is characterized in that including impulse generator
(1), at least one secondary transdermal patch (2) being connected by conducting wire with impulse generator (1), transdermal patch (2) is interior to be covered with electrode
(14), the transdermal patch (2) is equipped at least one jack (3) for being used to be inserted into needle thorn (4), is inserted with needle in jack (3)
It pierces (4), needle pierces (4) and connect with the conducting wire being located in transdermal patch (2).
2. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia according to claim 1, feature
It is, is located at jack (3) in the transdermal patch (2) and is provided with for transdermal patch (2) inside conductor to be connect with needle thorn (4)
Contact (5).
3. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia according to claim 2, feature
It is, the contact (5) includes the main body (6) of annular, and main body (6) is equipped with several by the surrounding reed that the heart extends thereto
(7), the end of each reed (7) in annular main body (6) center connect or cooperatively form carrying needle thorn (4) bearing holes (8),
The reed (7) is elastic construction.
4. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia according to claim 3, feature
It is, the end that the reed (7) is located at main body (6) center is equipped with anti-overturning of bending downward.
5. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia according to claim 4, feature
It is, needle thorn (4) ontology is equipped with anti-down line, and anti-down line and reed (7) cooperate.
6. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia according to claim 1, feature
It is, the corresponding Xiaguan point of at least one jack (3).
7. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia according to claim 1, feature
It is, the needle thorn (4) is 0.18*25mm acupuncture needle.
8. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia according to claim 1, feature
It is, the needle thorn (4) surface is equipped with scale.
9. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia according to claim 1, feature
It is, the transdermal patch (2) is three forked, and matches with trigeminal neuralgia distributed areas.
10. a kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia according to claim 1, feature
It is, the impulse generator (1) includes detection device (11) and is automatically turned off device (12).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820648943.9U CN209137759U (en) | 2018-05-03 | 2018-05-03 | A kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820648943.9U CN209137759U (en) | 2018-05-03 | 2018-05-03 | A kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209137759U true CN209137759U (en) | 2019-07-23 |
Family
ID=67263834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201820648943.9U Expired - Fee Related CN209137759U (en) | 2018-05-03 | 2018-05-03 | A kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209137759U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111214377A (en) * | 2019-12-19 | 2020-06-02 | 郑州神桥医疗器械有限公司 | An electro-acupuncture auxiliary fixation device |
| CN117257269A (en) * | 2023-11-23 | 2023-12-22 | 博奥生物集团有限公司 | Multifunctional integrated sensor for acupoint dose-effect diagnosis and treatment |
-
2018
- 2018-05-03 CN CN201820648943.9U patent/CN209137759U/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111214377A (en) * | 2019-12-19 | 2020-06-02 | 郑州神桥医疗器械有限公司 | An electro-acupuncture auxiliary fixation device |
| CN117257269A (en) * | 2023-11-23 | 2023-12-22 | 博奥生物集团有限公司 | Multifunctional integrated sensor for acupoint dose-effect diagnosis and treatment |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10695568B1 (en) | Device and method for the treatment of substance use disorders | |
| CN107427683B (en) | For can plant the improvement antenna and application method of nerve stimulator | |
| AU2009277037B2 (en) | Systems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain | |
| US20210393961A1 (en) | Devices and methods to use power spectrum or signal association for pain management | |
| KR20150127108A (en) | Cutaneous field stimulation with disposable and rechargeable components | |
| CN208541545U (en) | A kind of therapeutic device for treatment of insomnia patients based on mobile terminal | |
| CN105078747A (en) | Mobile phone adjusting and control interactive point joining acupuncture system based on cloud platform | |
| CN110392593A (en) | Utilize the vagal stimulation method and device of pulsed magnetic field | |
| CN209137759U (en) | A kind of semi-implantation type Blood oxygen saturation instrument for treating trigeminal neuralgia | |
| CN206675815U (en) | A kind of bracelet | |
| CN202909298U (en) | Nerve regulation instrument | |
| US20230277838A1 (en) | Vagal nerve stimulation therapy | |
| Ceccherelli et al. | Variables of stimulation and placebo in acupuncture reflexotherapy | |
| CN218636444U (en) | Transcranial micro-current stimulation sleeping instrument capable of playing 40Hz music | |
| CN108635670A (en) | System for carrying out human nerve stimulation based on forearm, finger tip and acupuncture | |
| US11458314B2 (en) | Method for configuring an electroanalgesia and electrotherapy apparatus | |
| CN208114884U (en) | Painless injection auxiliary device | |
| CN218010640U (en) | Closed loop percutaneous acupoint electrical stimulation equipment | |
| CN215230282U (en) | Electric acupuncture rehabilitation therapeutic apparatus | |
| US11420042B2 (en) | Systems and methods for delivering neurostimulation using exogenous electrodes | |
| US20220323745A1 (en) | Nerve stimulation therapy for maintaining telomere lengths | |
| Usichenko et al. | Auricular acupuncture | |
| Liu | Inhibiting pain with pain—A basic neuromechanism of acupuncture analgesia | |
| CN109498424A (en) | A kind of implantable nerve regulator control system | |
| CN105435366A (en) | Implanted neural adjustment and control system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190723 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |